What this study is
The SUpporting Seniors Receiving Treatment And INtervention (SUSTAIN) program is a telephone-based clinical service designed to help identify and manage behavioral health issues among PACE/PACENET enrollees. The purpose of the current project is to a) explore moderators of treatment response among beneficiaries in the SUSTAIN Clinical Program and b) to evaluate the sustained clinical effects of the program.
What's being tested
- SUSTAIN Monitoring and Care Management
Intervention · BEHAVIORAL
Program participants are offered clinical services based on symptom severity and clinical need. Follow-up Monitoring consists of up to 4 brief, structured assessments following the baseline clinical assessment. These follow-up contacts are conducted over the telephone by the HT/BHP and take place during the initial 12 weeks of pharmaceutical treatment. These brief interviews monitor symptoms, adherence, side effects, and response to treatment. Care Management incorporates the use of a BHP who has expertise in mental health assessment and is well versed in the delivery of algorithm-based management strategies. The BHP monitors and encourages patient acceptance and adherence to treatment recommendations through support, education, and motivational engagement.
Study details
- Sponsor
- University of Pennsylvania
- Conditions
- Depression · Anxiety · Pain, Chronic
- Enrolling
- 4,000 people
- Starts
- 2014-03
- Est. completion
- 2028-12
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 65 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Aged 65 and older, males and females.
- Participating in the SUSTAIN Clinical Program
- For the 6 Month Outcome Research Evaluation, in addition to meeting criteria 1 and 2, willing to provide verbal informed consent to participate in the 6 Month Outcome Research Evaluation at the end of the acute phase of clinical care, usually at three months.
You can't join if
- Not meeting the inclusion criteria listed above.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openDepartment of Psychiatry (Center for Psychotherapy Research), University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Mary Beth Gibbons, PhD · Contact(215)662-3488gibbonsm@pennmedicine.upenn.edu
- David W Oslin, MD · Sub-investigator
- Mary Beth Gibbons, PhD · Principal investigator
Recruiting
Study team
Sponsor
University of Pennsylvania
Study ID 819712
Principal investigator
Mary Beth Gibbons, PhD
University of Pennsylvania
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.